Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET

Abstract Background Dopamine transporter (DAT) imaging is used in the diagnostic work-up in suspected parkinsonian syndromes and dementia with Lewy bodies but cannot differentiate between these syndromes, and an extra brain imaging examination of the regional cerebral blood flow (rCBF) or glucose me...

Full description

Bibliographic Details
Main Authors: Susanna Jakobson Mo, Jan Axelsson, Lars Stiernman, Katrine Riklund
Format: Article
Language:English
Published: SpringerOpen 2022-11-01
Series:EJNMMI Research
Subjects:
Online Access:https://doi.org/10.1186/s13550-022-00941-8
_version_ 1811219361033093120
author Susanna Jakobson Mo
Jan Axelsson
Lars Stiernman
Katrine Riklund
author_facet Susanna Jakobson Mo
Jan Axelsson
Lars Stiernman
Katrine Riklund
author_sort Susanna Jakobson Mo
collection DOAJ
description Abstract Background Dopamine transporter (DAT) imaging is used in the diagnostic work-up in suspected parkinsonian syndromes and dementia with Lewy bodies but cannot differentiate between these syndromes, and an extra brain imaging examination of the regional cerebral blood flow (rCBF) or glucose metabolism is often needed for differential diagnosis. The requirement of two different imaging examinations is resource-consuming and inconvenient for the patients. Therefore, imaging of both cortical blood flow and DAT imaging with the same radiotracer would be more convenient and cost-effective. The aim of this study was to test whether relative regional cerebral blood flow (rCBFR) can be measured with the DAT-specific positron emission tomography (PET) tracer [18F]FE-PE2I (FE-PE2I), by validation with cerebral perfusion measured with [15O]H2O PET (H2O). Methods The rCBFR was quantified by kinetic modeling for FE-PE2I (R1) and H2O (F). The R1 was calculated using the simplified reference tissue model, and F was calculated with a modified Koopman double-integration method. The linear relationship and intraclass correlation (ICC) between R1 and F were tested in image data derived from 29 patients with recent onset parkinsonism and 30 healthy controls. Results There was a strong linear correlation across all subjects between R1 and F in the frontal, parietal, temporal, cingulate and occipital cortex as well as in the striatum (r  ≥  0.731–0.905, p  < 0.001) with a good-to-excellent ICC, ranging from 0.727 to 0.943 (p < 0.001). Conclusions Our results suggest that FE-PE2I may be used as a proxy for cerebral perfusion, thus potentially serving as a radiotracer for assessment of both DAT availability and rCBFR in one single dynamic scan. This could be valuable in the differential diagnosis of parkinsonian syndromes. Trial registration: EUDRA-CT 2015-003045-26. Registered 23 October 2015 https://www.clinicaltrialsregister.eu/ctr-search/search?query=2015-003045-26
first_indexed 2024-04-12T07:25:59Z
format Article
id doaj.art-54bb5c78c8b140b4b73e817a7554fb5f
institution Directory Open Access Journal
issn 2191-219X
language English
last_indexed 2024-04-12T07:25:59Z
publishDate 2022-11-01
publisher SpringerOpen
record_format Article
series EJNMMI Research
spelling doaj.art-54bb5c78c8b140b4b73e817a7554fb5f2022-12-22T03:42:12ZengSpringerOpenEJNMMI Research2191-219X2022-11-0112111010.1186/s13550-022-00941-8Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PETSusanna Jakobson Mo0Jan Axelsson1Lars Stiernman2Katrine Riklund3Department of Radiation Sciences, Diagnostic Radiology, Umeå UniversityUmeå Centre for Functional Brain Imaging (UFBI), Umeå UniversityUmeå Centre for Functional Brain Imaging (UFBI), Umeå UniversityDepartment of Radiation Sciences, Diagnostic Radiology, Umeå UniversityAbstract Background Dopamine transporter (DAT) imaging is used in the diagnostic work-up in suspected parkinsonian syndromes and dementia with Lewy bodies but cannot differentiate between these syndromes, and an extra brain imaging examination of the regional cerebral blood flow (rCBF) or glucose metabolism is often needed for differential diagnosis. The requirement of two different imaging examinations is resource-consuming and inconvenient for the patients. Therefore, imaging of both cortical blood flow and DAT imaging with the same radiotracer would be more convenient and cost-effective. The aim of this study was to test whether relative regional cerebral blood flow (rCBFR) can be measured with the DAT-specific positron emission tomography (PET) tracer [18F]FE-PE2I (FE-PE2I), by validation with cerebral perfusion measured with [15O]H2O PET (H2O). Methods The rCBFR was quantified by kinetic modeling for FE-PE2I (R1) and H2O (F). The R1 was calculated using the simplified reference tissue model, and F was calculated with a modified Koopman double-integration method. The linear relationship and intraclass correlation (ICC) between R1 and F were tested in image data derived from 29 patients with recent onset parkinsonism and 30 healthy controls. Results There was a strong linear correlation across all subjects between R1 and F in the frontal, parietal, temporal, cingulate and occipital cortex as well as in the striatum (r  ≥  0.731–0.905, p  < 0.001) with a good-to-excellent ICC, ranging from 0.727 to 0.943 (p < 0.001). Conclusions Our results suggest that FE-PE2I may be used as a proxy for cerebral perfusion, thus potentially serving as a radiotracer for assessment of both DAT availability and rCBFR in one single dynamic scan. This could be valuable in the differential diagnosis of parkinsonian syndromes. Trial registration: EUDRA-CT 2015-003045-26. Registered 23 October 2015 https://www.clinicaltrialsregister.eu/ctr-search/search?query=2015-003045-26https://doi.org/10.1186/s13550-022-00941-8Positron emission tomography18F FE-PE215O H2OCerebral blood flowCerebral perfusionParkinsonism
spellingShingle Susanna Jakobson Mo
Jan Axelsson
Lars Stiernman
Katrine Riklund
Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET
EJNMMI Research
Positron emission tomography
18F FE-PE2
15O H2O
Cerebral blood flow
Cerebral perfusion
Parkinsonism
title Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET
title_full Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET
title_fullStr Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET
title_full_unstemmed Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET
title_short Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET
title_sort validation of dynamic 18f fe pe2i pet for estimation of relative regional cerebral blood flow a comparison with 15o h2o pet
topic Positron emission tomography
18F FE-PE2
15O H2O
Cerebral blood flow
Cerebral perfusion
Parkinsonism
url https://doi.org/10.1186/s13550-022-00941-8
work_keys_str_mv AT susannajakobsonmo validationofdynamic18ffepe2ipetforestimationofrelativeregionalcerebralbloodflowacomparisonwith15oh2opet
AT janaxelsson validationofdynamic18ffepe2ipetforestimationofrelativeregionalcerebralbloodflowacomparisonwith15oh2opet
AT larsstiernman validationofdynamic18ffepe2ipetforestimationofrelativeregionalcerebralbloodflowacomparisonwith15oh2opet
AT katrineriklund validationofdynamic18ffepe2ipetforestimationofrelativeregionalcerebralbloodflowacomparisonwith15oh2opet